We have previously shown that the pulmonary venoconstriction produced by a stable thromboxane A 2 analogue (STA 2 ) is attenuated by prostacyclin (PGI 2 ), but PGI 2 increases the STA 2 -induced edema. The present study was designed to determine the effects of STA 2 and PGI 2 on the fluid balance in isolated blood-perfused newborn lamb lungs. Vascular permeability was evaluated by use of the fluid flitration coefficient (Kf) and the osmotic reflection coefficient for total proteins (<r, hematocrit-protein double indicator technique), and pulmonary capillary pressure (Pc) was estimated by the double occlusion technique. All lungs had a period of hydrostatic stress induced by elevation of the left atrial pressure from 5 to 20 mm Hg to promote fluid filtration, and the rate of lung weight gain (AW/AT) during this period was determined. Studies were made in four groups; before the hydrostatic stress, lungs were given 1) STA 2 (50 fig, «=6) , 2) PGI 2 (0.4 /ag/kg/min, n=6), 3) both PGI 2 and STA 2 (n=6), or 4) vehicles (control, it=5). Measurements of Kf were made at the baseline period and after the hydrostatic stress. Kf was significantly increased by 76% with STA 2 , by 121% with PGI 2 , and by 157% with both PGI 2 and STA 2 , but remained constant in controls. In comparison with control lungs, a similar AW/AT was observed with less of an increase in Pc during the hydrostatic stress in the STA 2 group, and greater values of AW/AT were obtained with smaller elevations in Pc in the groups receiving PGI 2 or both PGI 2 and STA 2 . The crof 0.66±0.07 in the control group was the highest in these experiments. Treatments with STA 2 and/or PGI 2 significantly decreased cr. These results suggest that both STA 2 and PGI 2 may increase pulmonary microvascular permeability to protein. Furthermore, PGI 2 may increase fluid filtration by increasing vascular surface area.
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We have previously shown that the pulmonary venoconstriction produced by a stable thromboxane A 2 analogue (STA 2 ) is attenuated by prostacyclin (PGI 2 ), but PGI 2 increases the STA 2 -induced edema. The present study was designed to determine the effects of STA 2 and PGI 2 on the fluid balance in isolated blood-perfused newborn lamb lungs. Vascular permeability was evaluated by use of the fluid flitration coefficient (Kf) and the osmotic reflection coefficient for total proteins (<r, hematocrit-protein double indicator technique), and pulmonary capillary pressure (Pc) was estimated by the double occlusion technique. All lungs had a period of hydrostatic stress induced by elevation of the left atrial pressure from 5 to 20 mm Hg to promote fluid filtration, and the rate of lung weight gain (AW/AT) during this period was determined. Studies were made in four groups; before the hydrostatic stress, lungs were given 1) STA 2 (50 fig, «=6), 2) PGI 2 (0.4 /ag/kg/min, n=6), 3) both PGI 2 and STA 2 (n=6), or 4) vehicles (control, it=5). Measurements of Kf were made at the baseline period and after the hydrostatic stress. Kf was significantly increased by 76% with STA 2 , by 121% with PGI 2 , and by 157% with both PGI 2 and STA 2 , but remained constant in controls. In comparison with control lungs, a similar AW/AT was observed with less of an increase in Pc during the hydrostatic stress in the STA 2 group, and greater values of AW/AT were obtained with smaller elevations in Pc in the groups receiving PGI 2 or both PGI 2 and STA 2 . The crof 0.66±0.07 in the control group was the highest in these experiments. Treatments with STA 2 and/or PGI 2 significantly decreased cr. These results suggest that both STA 2 and PGI 2 may increase pulmonary microvascular permeability to protein. Furthermore, PGI 2 may increase fluid filtration by increasing vascular surface area. (Circulation Research 1989; 65:1409 -1416 T hromboxane A 2 (TxA 2 ) is a potent pulmonary vasoconstrictor that may be involved in the early phase of endotoxin-induced pulmonary hypertension and edema. This pulmonary hypertensive response has been suggested to be the result of TxA 2 -mediated pulmonary venoconstriction since the protein-poor lung lymph flow is increased in this early phase. 1 -2 By use of the arterial and venous occlusion technique in isolated newborn lamb lungs, we have recently demonstrated that a stable TxA 2 analogue, 9,11-epithioll,12-methano-TxA 2 (STA 2 ), produced pulmonary hypertension primarily by causing pulmonary venoconstriction. 3 Although exogenous prostacyclin (PGI 2 ) attenuated this response to STA 2 by decreasing the pulmonary venoconstriction, PGI 2 administration significantly increased the STA 2induced pulmonary edema. 3 These observations were interpreted as being consistent with an increase in microvascular permeability by PGI 2 that potentiated the STA 2 -induced pulmonary edema, despite the attenuation of the elevation of the pulmonary microvascular pressure by PGI 2 . However, the possibility that PGI 2 increased lung vascular surface area rather than permeability was not completely excluded in this study because vascular permeability was not directly evaluated.
Pulmonary microvascular membrane permeability may be estimated by changes in filtration coefficient (Kf) in isolated perfused lungs. 4 However, when changes in the number of perfused microvessels occur, as with microvascular embolism, vasodilation, or vasoconstriction, Kf may not be a reliable parameter of changes in permeability because Kf depends on membrane surface area. 5 In sion of the Fenn effect is reconcilable with the PVA concept as has been suggested by Gibbs and Chapman. 15 To this end, we produced a specific set of isovolumic and ejecting contractions in the excised cross-circulated dog hearts whose LV volume was controlled and measured with a servo pump. We also studied whether the Fenn effect would be affected by enhanced and depressed contractile states and whether the additional Vo 2 of the ejecting contraction would always be proportional to its external work.
Materials and Methods Preparation
We used the excised cross-circulated dog heart preparation as described before. 10 -11 Briefly, two adult mongrel dogs (9-20 kg) were anesthetized with ketamine hydrochJoride (5 mg/kg i.m.) followed by sodium pentobarbital (25 mg/kg i.v.) in each experiment. The dogs were heparinized (1,000 units/kg). Arterial and venous cross-circulation tubes were cannulated into the common carotid arteries and jugular vein in the larger dog (support). The smaller dog (heart donor) was thoracotomized under artificial ventilation. The arterial and venous crosscirculation tubes from the support dog were cannulated into the left subclavian artery and the right ventricle (RV) via the right auricle, respectively. Then, the heart was isolated from the systemic and pulmonary circulation by ligating the azygos vein, descending aorta, inferior and superior venae cavae, brachiocephalic artery, and bilateral pulmonary hili. Cross circulation was then started. The donor heart was excised from the chest.
The left atrium was opened, and all chordae tendineae were cut. A thin rubber balloon with an unstressed volume from 55 to 60 ml was placed in the LV, and its mouth was fixed at the mitral anulus. The cable of a miniature pressure gauge (model P-7, Konigsberg Instruments, Pasadena, California), placed inside the apical end of the balloon, was pulled out of the ventricular apex through a stab incision. A balloon was connected to the same volume servo pump as described before, 11 and the balloon and pump were primed with water. The servo pump controlled LV volume precisely and measured it accurately.
The temperature of the heart was maintained between 35° and 37° C by warming the arterial cross-circulation tube coiled in a thermostat bath. Heart rate was fixed by electrically pacing the left atrium. LV surface electrocardiogram was used to trigger the volume servo pump in synchrony with ventricular contraction and to determine the onset of contraction.
The systemic arterial blood pressure of the support dog served as the coronary perfusion pressure. Systemic hypotension due to allergic reaction under cross circulation was prevented with diphenhydramine hydrochloride (30-60 mg i.m.). The mean
Ves Ved VOLU^E(ml) level of this pressure in all experiments was 70±12 mm Hg (mean±SD). It was relatively constant throughout each experiment and, when necessary, was corrected by transfusing blood collected from the heart donor dog, infusing 10% dextran solution, or giving phenylephrine (5-10 mg i.m.). The support dog was ventilated with room air, and arterial blood was occasionally sampled for measurements of pH, Po 2 , and Pa>2 with a blood gas analyzer (IL system 1303). Supplemental oxygen and intravenous sodium bicarbonate were given, when necessary, to maintain these parameters within their physiological ranges.
After the experiment, the LV including the septum and the RV were weighed. LV was 67.4±9.4 g, and RV was 27.3±5.8 g. The weight ratio of RV to (LV+RV) was 28.4±3.5%.
Pressure-Volume Area
PVA is the area circumscribed by the endsystolic pressure-volume line, the end-diastolic pressure-volume curve, and the systolic segment of the pressure-volume trajectory, 10 -12 -14 as shown in Figure 1 . PVA represents the total mechanical energy generated by a ventricular contraction. PVA consists of external mechanical work (EW) and mechanical potential energy (PE). 14 EW is the area under the systolic pressure-volume trajectory. PE is the area under the systolic pressure-volume relation line on the left side of EW. 14 We determined PVA, EW, and PE from ventricular pressure and volume data sampled on line at a rate of 500 Hz with a signal processing computer (model 7T-18, NEC San-ei). PVA was determined as the sum of small triangular areas with their apexes at the ventricular volume at 15 VOLUME (ml) I 15 VOLUME FIGURE 2. Graphs showing pressure-volume trajectories and isotonic curves. Panel A: Experimentally obtained pressure-volume trajectories of seven isovolumic and five quasi-isobaric ejecting (rectangular) contractions that are superimposed in the same pressure-volume diagram. The end-diastolic volumes of ejecting contractions were made equal to the volume of the greatest isovolumic contraction (Viv) . The volumes of the other isovolumic contractions except one at the volume axis intercept (Vo) were made equal to the corresponding end-systolic volumes of the five ejecting contractions. Pes, end-systolic pressure. Panel B: A family of isotonic curves (thin) and pressure-volume trajectories (thick) in a pressure-volume plane in the quasi-isotonic run. Each isotonic curve relates ventricular pressure (P) and volume (V) for a constant ventricular wall force (F): F=1.65 P-V w . Pressure-volume loops, in which ventricular pressure increased during ejection phase, show quasi-isotonic ejecting contractions. Isovolumic and quasi-isobaric ejecting (rectangular) contractions are also superimposed.
which peak pressure is zero (V o ) and their bases between adjacent (2 msec apart) pressure-volume data points on the systolic segment of the pressurevolume trajectory. 11 EW was obtained by subtracting PE from PVA. End systole of each contraction was identified as the time at which the P(t)/[V(t)-V 0 ] ratio became maximal. 16 This maximum pressurevolume ratio was identified as E^, of this contraction with P(t) and V(t) given as pressure and volume, respectively, as a function of time. We used E^* as an index of ventricular contractile state. 11 -16 For more details of the computer algorithm, see our previous paper. 11 PVA, EW, and PE were expressed in mm Hg ml/beat or in J/beat, where 1 mm Hg ml is physically equivalent to 1.33 xlO" 4 J. 11 
Oxygen Consumption
The total coronary flow was measured with an electromagnetic flowmeter (model MVF-2100, Ninon Kohden, Tokyo, Japan) by placing an in-line probe (model FF-050T, Nihon Kohden) in the venous cross-circulation tube that continuously drained all venous blood from the right heart. We neglected the LV thebesian venous blood flow because of its small fraction in the total coronary flow. 11 Coronary arteriovenous oxygen content difference was continuously measured with an AVOX system 17 that was calibrated against a Lex-O 2 -Con oxygencontent analyzer in each experiment. The bypassed venous blood was returned to the venous tube upstream of the flowmeter.
Vo? of the heart was determined as the product of coronary flow and arteriovenous oxygen content difference with the signal processor. Vo 2 per beat was obtained by dividing V02 per minute by heart rate in a steady state. We minimized the contribution and fluctuation of RV Vo 2 in the measured V02 regardless of LV PVA and Voj by keeping the RV collapsed by continuous hydrostatic drainage of the coronary venous blood from the right heart. We considered that Vo? of the collapsed RV was equal to RV weight/(LV weight-I-RV weight) times the total Vo 2 measured when the LV was also unloaded with zero PVA. This unloaded RV Vo 2 was subtracted from the measured total Vo 2 in each contractile state. Vo 2 was expressed in ml (Vbeat or J/beat, where 1 ml O 2 is biochemically equivalent to approximately 20 J. 18 E,^, PVA, EW, PE, and V02 were normalized for 100 g LV.
Protocol
Control run. A control run was performed without any inotropic interventions in 12 hearts. Steadystate isovolumic contraction was first produced at an LV volume of 20-30 ml. The peak pressure of this contraction (maximum end-systolic pressure in Figure 2A ) was between 80 and 170 mm Hg in the control before dobutamine and between 140 and 210 mm Hg in the control before propranolol. Then we alternately produced steady-state quasi-isobaric ejecting (rectangular pressure-volume loop) and isovolumic contractions in the following specific combinations. The end-diastolic volumes of these ejecting contractions were fixed at the same volume as in the initial isovolumic contraction. The end-diastolic volumes of the isovolumic contractions that followed these ejecting contractions Were set equal to the end-systolic volumes of the preceding ejecting contractions. We produced steady*state quasiisobaric ejecting contractions against five to six different afterload pressures from the same enddiastolic volume, as shown in Figure 2A . Stroke volumes of these ejecting contractions were made to range between 1.5 and 18.0 ml by changing the afterload pressure level. We finally produced unloaded contraction at V o (Figure 2 ). Data of all these contractions were collected in steady state and stored on a floppy disk of the signal processor.
Dobutamine run. In eight of these 12 dogs, contractile state was enhanced by a continuous intracoronary infusion of dobutamine at a rate of 5-15 fig/rain. Steady-state isovolumic and ejecting contractions were produced in the same specific combination as in the control run, and data were collected and stored on the floppy disk.
Propranolol run. In the other four of the 12 dogs, contractile state was depressed by a 0.2 mg intracoronary bolus injection of propranolol, followed by a continuous intracoronary infusion of propranolol at a rate of 15 /xg/min. Steady-state isovolumic and ejecting contractions were produced in the same specific combination as in the control run, and data were collected and stored on the floppy disk.
Quasi-isotonic (quasi-auxobaric) run. In two additional hearts, we attempted to produce quasi-isotonic contractions in addition to the specific combination of isovolumic and quasi-isobaric ejecting contractions that were used in the main runs. These quasiisotonic contractions were made to have the same end-diastolic and end-systolic volumes as the quasiisobaric ejecting contractions also produced in this run, as shown in Figure 2B . The quasi-isotonic contractions were made to increase LV pressure during ejection phase so that the ejecting pressurevolume trajectory followed closely one of the family of isotonic curves drawn in the pressure-volume plane by the following calculation. We calculated total circumferential wall force (F) of the LV by use of a spherical model. F was assumed to be equal to the product of the internal cross-sectional area (S) and intraventricular pressure (P): F(g)=S(cm 2 )-P (mm Hg), and thus, 1 mm Hg=1.36 g/cm 2 . 19 Since S=v (internal radius) 2 and ventricular internal volume (V)=(4W3)-(internal radius) 3 , S=1.21 V 20 . Therefore, F=1.65 P • V 2 *. 19 Then, a family of the isotonic curves 19 were drawn on the pressure-volume diagram by relating P and V so as to satisfy F=1.65 P • V", as shown in Figure 2B .
Curve Fitting
To compare the experimental data with theoretical prediction based on PVA, we used mathematical formulas to relate PVA, PE, EW, and E^ in the same way as before. 10 -20 The appendix describes the details of the mathematical formulation.
To obtain the appropriate coefficient values for the Equations relating PVA, PE, EW, and V02 to end-systolic pressure, we used a nonlinear regression technique. 21 We used the ready-made program (OPTIM, Tosaka) for a personal computer (model PC9801, NEC) and obtained the least-square-fit parameters in the same way as before. 22 
Statistics
Analysis of covariance 21 was applied to compare the regression lines of Vo 2 on PVA obtained in the control, dobutamine, and propranolol runs in each heart. Then, the differences of the slope and the elevation between the regression lines were tested by F test in each heart. Because of the high correlation coefficient between V02 and PVA in each of the control and dobutamine runs, we assumed little uncertainty in the estimated values for the slope and Vo2-axis intercept of the regression line in the same way as before. 13 Then, the slope and Vo2-axis intercept were compared between control and dobutamine runs in eight hearts and between control and propranolol runs in four hearts by two-way ANOVA. 21 Only when the F test was significant, the differences of the mean values of the slope and Vo 2 -axis intercept were tested by the least significant difference method. 21 Mean values for E^ of the variably loaded contractions were compared between the control and dobutamine runs and between the control and propranolol runs in each heart and in all hearts by paired t test. Values of p<0.05 were considered statistically significant. Data are presented as mean±SD. Figure 2A superimposes the pressure-volume trajectories of steady-state isovolumic and ejecting contractions in the specific combination as defined in "Materials and Methods." The left upper corners (end systoles) of the ejecting contractions were near the end-systolic (peak isovolumic) pressure-volume points of the corresponding isovolumic contractions. However, the end-systolic pressures of ejecting contractions with relatively small stroke volumes (1.5-5.0 ml) were slightly higher than those of the corresponding isovolumic contractions, as shown in Figure 2A . The end-systolic pressure of ejecting contraction with the largest stroke volume (9.0 ml) was slightly lower than that of the corresponding isovolumic contraction. These tendencies were similarly observed in all other hearts. Thus, we could not completely equalize the end-systolic pressures of each pair of ejecting and isovolumic contractions at the same end-systolic volume. Figure 2B shows pressure-volume trajectories of the quasi-isotonic ejecting contractions that had the same end-diastolic and end-systolic volumes as those of the corresponding quasi-isobaric (rectangular) ejecting contractions. However, we could not completely fit the quasi-isotonic pressure-volume loops during ejection phase for the theoretical isotonic curves derived from a spherical model because of the limitation of the performance of the servo pump. End-systolic pressures of the quasi-isotonic contractions were nearly equal to the corresponding quasi-isobaric ejecting and isovolumic contractions at the same end-systolic volumes.
Results

Pressure-Volume Diagram
The coefficient of variation (standard deviation/ mean value) of E^ in each run was 0.10±0.03. The mean value of E^ in all hearts was 7.6±2.3, 10.8±3.0, and 3.6±0.5 mm Hg/(ml/100 g LV) in control, dobutamine, and propranolol runs, respectively. The increase in E m u with dobutamine from control was 42±9% (/><0.01), and the decrease in E^ with propranolol from control was 58±20% (p<0.01). Figure 3 shows representative examples of the relation between V02 and PVA in control and dobutamine runs in one heart (panel A), in control and propranolol runs in another heart (panel B), and in the quasi-isotonic run in a third heart (panel C). Eŵ as significantly increased by 48% with dobutamine in panel A and decreased by 70% with propranolol in panel B. In each run, the correlation between V02 and PVA was good, and the Vo 2 -PVA data points were closely fitted by a linear regression line in panels A, B, and C. The data points of isovolumic, quasi-isobarically ejecting, and quasi-isotonically ejecting contractions were on the same Voj-PVA regression line in panel C. Thus, the V02-PVA relation in a given heart in any stable contractile state was independent of the loading conditions, that is, whether the contractions were isovolumic or ejecting. The summary of correlation and regression analyses of the Vo^-PVA relation is shown in Table 1 . Heart rate was constant in each run, and the mean heart rate in all experiments was 165±9 beats/min. The correlation coefficient between V02 and PVA was always close to unity in any run in all hearts.
Vo 2 -PVA Relation
In Figure 3 , the Vo 2 -PVA regression line in the dobutamine run was considerably higher than that in the control run in panel A, and the V02-PVA regression line in the propranolol run was lower than that in the control run in panel B. Analysis of covariance shows that the elevation of the regression lines was significant (/?<0.01) in panels A and B, and the difference of the slope was not significant in either panel A or B. This indicates that the upward shift by dobutamine and the downward shift by propranolol were virtually parallel in individual .hearts. The control Vo^PVA regression line in panel A was lower than the control line in panel B because E^ of the control state in panel A happened to be lower than that in panel B in the two different hearts. In all the other hearts, dobutamine always significantly elevated the regression line but did not significantly change the slope except in one heart. In this heart, the slope significantly increased from 2.12 to 2.85 by dobutamine (/?<0.05). Propranolol significantly lowered the regression line but did not change the slope in all four hearts. Therefore, the upward or downward shift of the V02-PVA regression line with dobutamine or propranolol, respectively, was generally in parallel with the control line in individual hearts.
Voj-End-Systolic Pressure Relation
In Figure 4 , panels A and B show representative examples of the data points of quasi-isobarically ejecting and isovolumic contractions in the control and dobutamine runs in one heart (panel A) and those in the control and propranolol runs in another heart (panel B). Vo 2 in ejecting contraction was greater than that in isovolumic contraction at any comparable end-systolic pressure in each of control, dobutamine, and propranolol runs. Dobutamine increased Voj and propranolol decreased V02 of both ejecting and isovolumic contractions. These experimental data of isovolumic and ejecting contractions in each run were separately fitted by the two theoretical curves (Equations 5 and 6 in the Appendix as shown in Figure 4A and 4B). The curve fitted to ejecting contractions was always convex upward, and the curve fitted to isovolumic contractions was always convex downward. The two curves merged together near both ends, namely, near zero and maximum end-systolic pressures. Similar parabolic Vc^-fitting curves were obtained in all hearts. Dobutamine elevated these curves, and propranolol lowered them. AV02 curves at the bottom of the graphs in Figure 4 show the difference between the Vo2-fitting curve of isovolumic contractions and the curve of ejecting contractions. The AVo 2 curve was always parabolic downward in any of the control, dobutamine, and propranolol runs. Figure 4C shows that Vo 2 of the quasi-isotonic contraction was slightly lower than that of the corresponding quasi-isobaric contraction at the same end-systolic volume. The difference between them increased as end-systolic pressure decreased with increases in stroke volume. However, Vo 2 of quasi-isotonic contraction was still greater than that of the corresponding isovolumic contraction at any comparable end-systolic pressure. A similar result was obtained in the other heart subjected to the quasi-isotonic run.
PVA-PE-, and EW-End-Systolic Pressure Relations
We also fitted parabolic curves (Equations 1, 2, and 3 in the Appendix) relating PE, EW, and PVA to end-systolic pressure. Figure 5 shows the representative examples of these fitting curves (solid) in control (panel A), dobutamine (panel B), and propranolol (panel C) runs in the same hearts as shown in Figures 4A and 4B . The PE curve (solid) obtained from the ejecting contractions was concave upward, and the EW curve was parabolic downward. EW was maximal near one half of maximum endsystolic pressure in each run. The PVA curve of the ejecting contractions was the sum of these PE and EW curves and was concave downward. The data points of ejecting contractions were close to these PE-, EW-, and PVA-fitting curves in each run. The PVA data points of the isovolumic contractions, where PVA=PE, were almost on the PE curve (solid) of the ejecting contractions. The PVA curves (dotted) of the isovolumic contractions were concave upward and very close to the corresponding Figures  5A, 5B, and 5C . In all other hearts, we obtained similar PE-, EW-, and PVA-fitting curves as functions of endsystolic pressure regardless of the control, dobutamine, and propranolol runs. EW values always became maximal near one half of maximum endsystolic pressure in each run. The PVA curves obtained from the isovolumic contractions were very close to the PE curves obtained from the ejecting contractions in all the hearts.
PE curves of the ejecting contractions in
Excess Vo 2 Versus PVA
In the present study, the slope coefficient of the V02-PVA regression line (coefficient A in Equation 4) was 2.27±0.32 and nearly constant regardless of loading conditions and ^ma, as shown in Table 1 . The reciprocal of the slope coefficient A was assumed to indicate the energy conversion effi-ciency (Ec) from excess V02, which is total Vo 2 minus unloaded V02, to PVA, as explained in an earlier publication. 11 Ec was approximately constant at 44.0±6.1%.
Multiplication of the excess Vo? curves by the Ec value produced curves that could be compared with the PVA versus end-systolic pressure curves. In Figure 5 , panels D, E, and F show the curves obtained by these two different methods in the same hearts as shown in panels A, B, and C. The solid curves (Ecx excess V02 curves) were obtained by the multiplication of the excess Vo? curves by Ec, and the dotted curves (PVA curves) are the PVAfitting curves. The solid and dotted curves closely resembled each other in both isovolumic and ejecting contractions. In all other hearts, these two curves also resembled each other in both isovolumic and ejecting contractions regardless of the control, dobutamine, or propranolol runs. In panels D, E, and F, Aexcess V02 curves show the difference between the Ecx excess V02 curves of ejecting and isovolumic contractions, and APVA curves show the difference between the PVA curves of the same ejecting and isovolumic contractions. Both Aexcess Vo? and APVA curves were parabolic downward and very close to each other in the control run, dobutamine run, and propranolol run. Figure 6 shows the scatter diagram of the additional V02 (AV02) values of all ejecting contractions above V02 values of the corresponding isovolumic contractions plotted against EW of the same ejecting contractions in all of the control, dobutamine, propranolol, and quasi-isotonic runs. There was a close and linear correlation between AVo? and EW with a correlation coefficient of 0.88 (/?<0.01). The slope coefficient of this regression line was 2.14 (dimensionless), and AV02 intercept of the regression line was almost zero. This slope coefficient was close to the slope coefficient of the V02-PVA relation listed in Table 1 . This slope coefficient indicates inversely the efficiency of energy conversion from AVoj to EW. This efficiency was 47%. The slope coefficient of the AV02-EW relation was not significantly different among the experimental runs (1.88 in the control run, 2.23 in the dobutamine run, and 2.00 in the propranolol run), and neither were the efficiency values among them (53%, 45%, and 50%, respectively).
Discussion
The present results show that V02 in an ejecting contraction was always greater by an amount proportional to its EW than Vo? in the corresponding isovolumic contraction having the same endsystolic pressure and volume as this ejecting contraction. This effect of EW on V02 indicates the difference of energy utilization between the ejecting and isovolumic contractions. This is evidence of the Fenn effect in the dog LV. The present study shows that the Fenn effect can be reconciled with the PVA concept. 11 -12 -14 When V02 values in ejecting and isovolumic contractions are expressed as functions of end-systolic pressure, the difference (AV02) of these V02 curves looks analogous to EW (part of PVA) as a function of end-systolic pressure, as seen in Figures 4 and 5 . The similarity of the AV02 curve multiplied by Ec to the EW curve as well as the linear AV02-EW relation supports the relatively constant stoichiometry between AV02 and EW. This is also evidence of the Fenn effect in a more quantitative way.
The present results show that AVo? between ejecting and isovolumic contractions at matched end-systolic pressure and end-systolic volume is compatible with the load-independent linear Vo 2 -PVA relation. PVA correlates linearly with V02 in a given LV in any stable contractile state in this study in the same way as in our previous studies. 10 -13 The parallel elevation of the V02-PVA regression line by dobutamine is similar to that caused by epinephrine or elevated calcium. 11 The V02-PVA regression line is lowered in a parallel manner by propranolol. The parallel shift is evidenced by the relatively constant slope of the Voj-PVA regression line regardless of contractile states and the mode of contraction ( Table  1 ). The sensitive change in V02 intercept by contractile state (Table 1) is similar to that observed in our previous study. 11 The relatively constant Ec from the excess V02 (total Voj-unloaded V02) to PVA of 44% (Table 1) , which is the reciprocal of the slope coefficient, was consistent with the constant efficiency from AV02 to EW of 47% ( Figure 6 ). Moreover, the efficiency from AV02 to EW was comparable among the control, dobutamine, and propranolol runs ( Figure  6 ). These findings indicate that the Vo 2 cost of unit PVA is equal to that of unit EW regardless of the contractile states, and hence, as greater EW is performed, greater V02 is required for the work. Thus, the V03-PVA relation is compatible with the Fenn effect.
We assumed in the present study that 1 ml O 2 is biochemically equivalent to approximately 20 J. This calorific equivalent ranges between 19.36 and 20.84 J and is only slightly (±5%) affected by substrates. 23 Therefore, changes, if any, in the metabolic substrates would have a negligible effect in the present study.
Mommaerts 24 recommended the use of an "equivalent force base line" for comparing isotonic and isometric contractions to avoid the confusions about the generality of Fenn's observations. This approach helps unify the concept of the Fenn effect. 3 In the heart, however, wall force is not constant (isotonic); it decreases during the ordinary quasiisobaric ejection. 25 The force during the early ejection phase is greater than end-systolic force in quasi-isobaric ejecting contractions, as seen in Fig-ure 2B. By contrast, the pressure-volume trajectories of quasi-isotonic ejecting contractions were made close during ejection phase to the theoretical isotonic curves on the pressure-volume diagram, as shown in Figure 2B . Comparison of the quasiisobaric and quasi-isotonic contractions in Figure  2B shows that EW of the quasi-isotonic contraction is smaller by the triangular areas between the quasiisobaric and quasi-isotonic pressure-volume trajectories during ejection than the corresponding quasiisobaric contraction with the same end-diastolic and end-systolic volumes. In plotting AV02 and EW data in Figure 6 , quasi-isobaric and quasi-isotonic ejecting contractions were superimposable; this finding indicates that the V02 energy cost of unit EW is always relatively constant regardless of contractile force during ejection. Therefore, the smaller EW of the quasi-isotonic contraction is considered to cause a proportionally smaller V02, as seen in Figure 4C . This result also supports the existence of the Fenn effect in the heart.
The Fenn effect of the LV that we observed in this study is consistent with that of myocardium. 15 - 26 Gibbs 26 showed in papillary muscle that the relation between total isotonic enthalpy and load is curvilinear (concave downward). Moreover, the ratio of the total isotonic enthalpy minus activation heart to the sum of EW and PE, which was calculated from the tension-length relation, is constant regardless of different loads. 26 This similarity between rabbit papillary muscle and dog LV suggests that the concept of PVA may have widespread application to cardiac energetics.
In summary, we have examined the additional cardiac energy utilization associated with EW in the excised cross-circulated dog LV. V02 in both isovolumic and ejecting contractions could be fitted by the theoretical curves as functions of end-systolic pressure derived from the concept of PVA. The Vo 2 curve for isovolumic contractions was concave upward and that for ejecting contractions was concave downward. Vo 2 in ejecting contractions was greater than that in isovolumic contractions by an amount proportional to EW. Thus, we could show that the additional energy utilization that accompanies EW production, that is, the Fenn effect, is reconcilable with the PVA concept. Appendix As seen in Figure 1 
where Ves is end-systolic volume, Ved is enddiastolic volume, V o is volume at which peak pressure is zero, and SV is stroke volume. In Equations 1 and 2, we assume for simplicity that ventricular pressure during ejection is constant, that is, isobaric, and equal to Pes as shown in Figure 1 . Thus, PVA, PE, and EW can be mathematically expressed as quadratic functions of Pes. In the present study, E^ and V o were practically constant in each run, and Ved in ejecting contractions was also constant in each run as described in "Results." Since PVA, PE, and EW are quadratic functions of Pes, the experimental data could be fitted with the appropriate equations. The empirical relation between PVA and V02 has been shown to be formulated as follows 10 -11 -20 :
Vo2=A-PVA+B=A-(PE+EW)+B (4) where A is constant regardless of loading conditions and £",", and B is a function of E^ and independent of loading conditions. In isovolumic contractions, from Equations 1 and 4, Thus, V02 is also expressed as a quadratic function of Pes. The present experimental data were fitted with the quadratic equation relating Vo 2 to Pes.
